118 related articles for article (PubMed ID: 25191796)
21. Wilms tumor 1 expression present in most melanomas but nearly absent in nevi.
Perry BN; Cohen C; Govindarajan B; Cotsonis G; Arbiser JL
Arch Dermatol; 2006 Aug; 142(8):1031-4. PubMed ID: 16924053
[TBL] [Abstract][Full Text] [Related]
22. WT 1 expression in nevi and melanomas: a marker of melanocytic invasion into the dermis.
Garrido-Ruiz MC; Rodriguez-Pinilla SM; Pérez-Gómez B; Rodriguez-Peralto JL
J Cutan Pathol; 2010 May; 37(5):542-8. PubMed ID: 19638168
[TBL] [Abstract][Full Text] [Related]
23. Integrating clinical/dermatoscopic findings and fluorescence in situ hybridization in diagnosing melanocytic neoplasms with less than definitive histopathologic features.
Nardone B; Martini M; Busam K; Marghoob A; West DP; Gerami P
J Am Acad Dermatol; 2012 Jun; 66(6):917-22. PubMed ID: 21962759
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor expression in malignant melanoma: prognostic versus diagnostic usefulness.
Bayer-Garner IB; Hough AJ; Smoller BR
Mod Pathol; 1999 Aug; 12(8):770-4. PubMed ID: 10463478
[TBL] [Abstract][Full Text] [Related]
25. [Immunohistochemical markers for cytoplasmic antigens in acquired melanosis, malignant melanomas, and nevi of the conjunctiva].
Hitzer S; Bialasiewicz AA; Richard G
Klin Monbl Augenheilkd; 1998 Oct; 213(4):230-7. PubMed ID: 9848068
[TBL] [Abstract][Full Text] [Related]
26. Melanoma mimicking dermal and Spitz's nevus ("nevoid" melanoma).
Wong TY; Duncan LM; Mihm MC
Semin Surg Oncol; 1993; 9(3):188-93. PubMed ID: 8516601
[TBL] [Abstract][Full Text] [Related]
27. Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions.
Zembowicz A; Yang SE; Kafanas A; Lyle SR
Arch Pathol Lab Med; 2012 Dec; 136(12):1571-9. PubMed ID: 22480223
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of cytoplasmic p27 expression in human melanoma.
Chen G; Cheng Y; Zhang Z; Martinka M; Li G
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2212-21. PubMed ID: 21828232
[TBL] [Abstract][Full Text] [Related]
29. Pitfalls in the evaluation of melanocytic lesions.
Brenn T
Histopathology; 2012 Apr; 60(5):690-705. PubMed ID: 22176022
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical studies of conjunctival nevi and melanomas.
Jakobiec FA; Bhat P; Colby KA
Arch Ophthalmol; 2010 Feb; 128(2):174-83. PubMed ID: 20142539
[TBL] [Abstract][Full Text] [Related]
31. Ki-67 and p53 expression in minimal deviation melanomas as compared with other nevomelanocytic lesions.
Chorny JA; Barr RJ; Kyshtoobayeva A; Jakowatz J; Reed RJ
Mod Pathol; 2003 Jun; 16(6):525-9. PubMed ID: 12808056
[TBL] [Abstract][Full Text] [Related]
32. JARID1B expression in human melanoma and benign melanocytic skin lesions.
Kuźbicki L; Lange D; Strączyńska-Niemiec A; Chwirot BW
Melanoma Res; 2013 Feb; 23(1):8-12. PubMed ID: 23262439
[TBL] [Abstract][Full Text] [Related]
33. Potentially useful markers for desmoplastic melanoma: an analysis of KBA.62, p-AKT, and ezrin.
Bernaba BN; Vogiatzis PI; Binder SW; Cassarino DS
Am J Dermatopathol; 2011 Jun; 33(4):333-7; quiz 338-40. PubMed ID: 21610456
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical diagnostic and prognostic markers for melanoma.
Nosrati M; Kashani-Sabet M
Methods Mol Biol; 2014; 1102():259-73. PubMed ID: 24258983
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemistry of p16 in nevi of pregnancy and nevoid melanomas: a clinical follow-up study.
Koh SS; Lau SK; Roehmholdt BF; Cassarino DS
J Clin Pathol; 2022 Jan; 75(1):68-70. PubMed ID: 33753560
[No Abstract] [Full Text] [Related]
36. Identification and functional characterization of ASK/Dbf4, a novel cell survival gene in cutaneous melanoma with prognostic relevance.
Nambiar S; Mirmohammadsadegh A; Hassan M; Mota R; Marini A; Alaoui A; Tannapfel A; Hegemann JH; Hengge UR
Carcinogenesis; 2007 Dec; 28(12):2501-10. PubMed ID: 17768177
[TBL] [Abstract][Full Text] [Related]
37. Combined melanocytic nevi: histologic variants and melanoma mimics.
Baran JL; Duncan LM
Am J Surg Pathol; 2011 Oct; 35(10):1540-8. PubMed ID: 21881487
[TBL] [Abstract][Full Text] [Related]
38. Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study.
Nazarian RM; Prieto VG; Elder DE; Duncan LM
J Cutan Pathol; 2010 Apr; 37 Suppl 1():41-7. PubMed ID: 20482674
[TBL] [Abstract][Full Text] [Related]
39. Lack of correlation between immunohistochemical expression of CKIT and KIT mutations in atypical acral nevi.
Park E; Yang S; Emley A; DeCarlo K; Richards J; Mahalingam M
Am J Dermatopathol; 2012 Feb; 34(1):41-6. PubMed ID: 22094233
[TBL] [Abstract][Full Text] [Related]
40. Depletion of primary cilium in acral melanoma.
Love NR; Lang UE; Cheung C; Kim J
J Cutan Pathol; 2019 Sep; 46(9):665-671. PubMed ID: 31020686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
